MENU

International Trade Commission to investigate ResMed copycats

ResMed (ASX: RMD) shareholders might be able to sleep better at night after today’s news. The company announced today that the International Trade Commission (ITC) has agreed to investigate Chinese company BMC Medical and its Florida-based distributors for possible patent infringement.

ResMed alleges that BMC has copied several of its key inventions, including “positive airway passage” devices, nasal pillows, and nasal mask. ResMed is also suing BMC in federal U.S. courts, and is currently in the midst of similar legal action against Taiwanese manufacturer Apex Medical.

“We’re encouraged by the ITC’s action to investigate this case against BMC,” said ResMed Global General Counsel and Chief Administrative Officer David Pendarvis in a statement. “For more than two decades, ResMed has generated significant advances in innovative products for sleep-disordered breathing therapy. We invest over $100 million in research and development each year to fuel these advances and other companies should not be allowed to infringe ResMed’s intellectual property by using our technology.”

Australia’s full of innovation, and two of the country’s most promising small companies are still flying under the radar. Discover these two exciting ASX investments in our brand-new special FREE report, “2 Small Cap Superstars”. Click here now, it’s free!

More reading


Motley Fool contributor Justin Loiseau has no position in any stocks mentioned in this article. You can follow him on Twitter @TMFJLo.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.